Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV)

CUSIP: G4766E116

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
Shares outstanding
125,610,040
Total 13F shares
64,306,768
Share change
-586,118
Total reported value
$1,024,584,616
Put/Call ratio
103%
Price per share
$16.12
Number of holders
95
Value change
-$11,033,099
Number of buys
44
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP G4766E116?
CUSIP G4766E116 identifies INDV - Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) as of Q2 2024

As of 30 Jun 2024, Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,306,768 shares. The largest 10 holders included Two Seas Capital LP, FMR LLC, SCOPIA CAPITAL MANAGEMENT LP, BARCLAYS PLC, VANGUARD GROUP INC, OAKTREE CAPITAL MANAGEMENT LP, BANK OF AMERICA CORP /DE/, NORGES BANK, UBS Group AG, and GOLDMAN SACHS GROUP INC. This page lists 95 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.